Is AMARIN CORP PLCUK (AMRN) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 2.6% / 30% | 100.6% / 30% | 41.8% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 2.6% / 33% | 100.6% / 33% | 41.8% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 1.1% / 33% | 42.9% / 33% | 17.8% / 33% | N/A | ✗ NOT HALAL |
| S&P | 2.6% / 33% | 100.6% / 33% | 41.8% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 1.1% / 33% | 42.9% / 33% | 17.8% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 56.6% | |
| Operating Margin | -4.6% | |
| Net Margin | -18.2% | |
| Return on Equity (ROE) | -8.2% | |
| Return on Assets (ROA) | -1.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $7M |
| Free Cash Flow | $7M |
| Total Debt | $6M |
| Debt-to-Equity | 1.8 |
| Current Ratio | 3.3 |
| Total Assets | $671M |
Price & Trading
| Last Close | $14.67 |
| 50-Day MA | $15.03 |
| 200-Day MA | $15.60 |
| Avg Volume | 90K |
| Beta | 0.9 |
|
52-Week Range
$7.60
| |
About AMARIN CORP PLCUK (AMRN)
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is AMARIN CORP PLCUK (AMRN) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), AMARIN CORP PLCUK is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is AMARIN CORP PLCUK's debt ratio?
AMARIN CORP PLCUK's debt ratio is 2.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 1.1%.
What are AMARIN CORP PLCUK's key financial metrics?
AMARIN CORP PLCUK has a market capitalization of $301M, and revenue of $214M. The company maintains a gross margin of 56.6% and a net margin of -18.2%. Return on equity stands at -8.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.